These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins. Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741 [TBL] [Abstract][Full Text] [Related]
5. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases. Cho CH; Nuttall ME Expert Opin Ther Targets; 2002 Dec; 6(6):679-89. PubMed ID: 12472380 [TBL] [Abstract][Full Text] [Related]
6. Functional cell-based uHTS in chemical genomic drug discovery. Croston GE Trends Biotechnol; 2002 Mar; 20(3):110-5. PubMed ID: 11841862 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. Vanover KE; Weiner DM; Makhay M; Veinbergs I; Gardell LR; Lameh J; Del Tredici AL; Piu F; Schiffer HH; Ott TR; Burstein ES; Uldam AK; Thygesen MB; Schlienger N; Andersson CM; Son TY; Harvey SC; Powell SB; Geyer MA; Tolf BR; Brann MR; Davis RE J Pharmacol Exp Ther; 2006 May; 317(2):910-8. PubMed ID: 16469866 [TBL] [Abstract][Full Text] [Related]
9. Fulfilling the promise: drug discovery in the post-genomic era. Chanda SK; Caldwell JS Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711 [TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733 [TBL] [Abstract][Full Text] [Related]
12. Functional genomic and high-content screening for target discovery and deconvolution. Heynen-Genel S; Pache L; Chanda SK; Rosen J Expert Opin Drug Discov; 2012 Oct; 7(10):955-68. PubMed ID: 22860749 [TBL] [Abstract][Full Text] [Related]
13. Chemical genomics and emerging DNA technologies in the identification of drug mechanisms and drug targets. Olsen LC; Færgeman NJ Curr Top Med Chem; 2012; 12(12):1331-45. PubMed ID: 22690680 [TBL] [Abstract][Full Text] [Related]
15. Anticancer drug discovery using chemical genomics. Sehgal A Curr Med Chem; 2003 May; 10(9):749-55. PubMed ID: 12678778 [TBL] [Abstract][Full Text] [Related]
16. Massively parallel screening of the receptorome. Jensen NH; Roth BL Comb Chem High Throughput Screen; 2008 Jul; 11(6):420-6. PubMed ID: 18673270 [TBL] [Abstract][Full Text] [Related]
17. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models. Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387 [TBL] [Abstract][Full Text] [Related]
18. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. Herrick-Davis K; Grinde E; Teitler M J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983 [TBL] [Abstract][Full Text] [Related]
19. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438 [TBL] [Abstract][Full Text] [Related]
20. Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery. Ottl J; Leder L; Schaefer JV; Dumelin CE Molecules; 2019 Apr; 24(8):. PubMed ID: 31027189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]